Fig. 4From: Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective studySurvival analysis of A PFS from Regorafenib-start time for Treatment line ≥ 2; B OS from Regorafenib-start time for Treatment line ≥ 2; C PFS from 1st HAIC-start time for Treatment line ≥ 2; D OS from 1st HAIC-start time for Treatment line ≥ 2. PFS, progression-free survival; OS, overall survival; HAIC, hepatic arterial infusion chemotherapyBack to article page